Ayala Pharmaceuticals Inc (ADXS)

[lorema]

Section 16 of the 1934 Act requires a public company’s officers, directors and holders of more than 10% of any class of equity security to report their transactions in such company’s securities and to disgorge certain “short-swing profits.”